Organon & (OGN) Sɔɔtɔ Fɔrɛkɛst
Organ & Co.
Nɔnyɔ nyɛ$13.73Nɔɔ 25 Gbo 2026 19:59 UTC
Nyuɛ+0.07%
AI forecast: OGN
AI bɔɔ target price fɔ trading day tɛnɛ, week ɛnɛ ɛkpɔ month ɛnɛ ɛkɛ. Change bɔɔ latest price lɛ. Statistical estimates lɛ, not investment advice.
Nɔnyɔ ɔhɛ 6 dɛnɛ a akɛ
Premium shows the AI's price targets for 1 day, 1 week and 1 month for this and every other stock.
Unlock Premium🔒 Nɔ nyɛmɛ nyɛ nyɛmɛ
The forecast track record — every past forecast next to the actual close — is part of Premium.
Unlock PremiumƐŋɛ Nɛ Kɔmpɔni A
Organon & Co. is a global pharmaceutical company operating in the women’s health, biosimilars, and popular brands segments. The company develops contraceptives and fertility treatments, immunology products and oncology drugs, as well as a broad range of cardiovascular, respiratory, dermatological, and non-opioid therapy medications.
